BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 16492667)

  • 41. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
    Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
    Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
    Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nerve growth factor stimulation of p42/p44 mitogen-activated protein kinase in PC12 cells: role of G(i/o), G protein-coupled receptor kinase 2, beta-arrestin I, and endocytic processing.
    Rakhit S; Pyne S; Pyne NJ
    Mol Pharmacol; 2001 Jul; 60(1):63-70. PubMed ID: 11408601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation.
    Gesty-Palmer D; Flannery P; Yuan L; Corsino L; Spurney R; Lefkowitz RJ; Luttrell LM
    Sci Transl Med; 2009 Oct; 1(1):1ra1. PubMed ID: 20368153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.
    Szereszewski JM; Pampillo M; Ahow MR; Offermanns S; Bhattacharya M; Babwah AV
    PLoS One; 2010 Sep; 5(9):e12964. PubMed ID: 20886089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
    Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
    Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins.
    Camiña JP; Lodeiro M; Ischenko O; Martini AC; Casanueva FF
    J Cell Physiol; 2007 Oct; 213(1):187-200. PubMed ID: 17525997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase.
    Freedman NJ; Liggett SB; Drachman DE; Pei G; Caron MG; Lefkowitz RJ
    J Biol Chem; 1995 Jul; 270(30):17953-61. PubMed ID: 7629102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids.
    Candelario J; Tavakoli H; Chachisvilis M
    PLoS One; 2012; 7(12):e52583. PubMed ID: 23300710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.
    Kim J; Ahn S; Ren XR; Whalen EJ; Reiter E; Wei H; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1442-7. PubMed ID: 15671181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.
    Zhou Q; Li G; Deng XY; He XB; Chen LJ; Wu C; Shi Y; Wu KP; Mei LJ; Lu JX; Zhou NM
    Br J Pharmacol; 2012 Jul; 166(6):1756-73. PubMed ID: 22289163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling.
    Barthet G; Framery B; Gaven F; Pellissier L; Reiter E; Claeysen S; Bockaert J; Dumuis A
    Mol Biol Cell; 2007 Jun; 18(6):1979-91. PubMed ID: 17377064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Negative regulation of parathyroid hormone (PTH)-activated phospholipase C by PTH/PTH-related peptide receptor phosphorylation and protein kinase A.
    Tawfeek HA; Abou-Samra AB
    Endocrinology; 2008 Aug; 149(8):4016-23. PubMed ID: 18450967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3',5'-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway.
    Kawane T; Mimura J; Yanagawa T; Fujii-Kuriyama Y; Horiuchi N
    J Endocrinol; 2003 Aug; 178(2):247-56. PubMed ID: 12904172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective modulation of follicle-stimulating hormone signaling pathways with enhancing equine chorionic gonadotropin/antibody immune complexes.
    Wehbi V; Decourtye J; Piketty V; Durand G; Reiter E; Maurel MC
    Endocrinology; 2010 Jun; 151(6):2788-99. PubMed ID: 20332198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
    Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
    Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
    Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
    J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structurally diverse N-terminal peptides of parathyroid hormone (PTH) and PTH-related peptide (PTHRP) inhibit the Na+/H+ exchanger NHE3 isoform by binding to the PTH/PTHRP receptor type I and activating distinct signaling pathways.
    Azarani A; Goltzman D; Orlowski J
    J Biol Chem; 1996 Jun; 271(25):14931-6. PubMed ID: 8663042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways.
    Yue L; Haroun S; Parent JL; de Brum-Fernandes AJ
    Bone; 2014 Mar; 60():112-21. PubMed ID: 24345643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.